Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginNet MarginOperating MarginReturn on Sales

ENDRA Life Sciences (NDRA) Return on Sales (2016 - 2018)

ENDRA Life Sciences (NDRA) has disclosed Return on Sales for 3 consecutive years, with 1586.7% as the latest value for Q4 2018.

  • Quarterly Return on Sales fell 125171.0% to 1586.7% in Q4 2018 from the year-ago period, while the trailing twelve-month figure was 1586.7% through Dec 2018, down 157140.0% year-over-year, with the annual reading at 98.67% for FY2025, 741.0% up from the prior year.
  • Return on Sales for Q4 2018 was 1586.7% at ENDRA Life Sciences, down from 746.72% in the prior quarter.
  • The five-year high for Return on Sales was 3.11% in Q2 2016, with the low at 1586.7% in Q4 2018.
  • Average Return on Sales over 3 years is 318.96%, with a median of 25.52% recorded in 2017.
  • Peak annual rise in Return on Sales hit -147bps in 2018, while the deepest fall reached -125171bps in 2018.
  • Over 3 years, Return on Sales stood at 1.34% in 2016, then plummeted by -24971bps to 334.98% in 2017, then tumbled by -374bps to 1586.7% in 2018.
  • According to Business Quant data, Return on Sales over the past three periods came in at 1586.7%, 746.72%, and 26.25% for Q4 2018, Q3 2018, and Q2 2018 respectively.